Interaction of mercury with human erythrocytes.
The binding of mercury to red blood cells was measured in terms of Hg(203) uptake and desorption. The significant features of the binding are: (a) rapid achievement of equilibrium (3 to 5 minutes); (b) release of a Hg-complexing material from the red cells themselves which distorts the binding curves at low concentrations of metal (2.5 x 10(-7) to 5.0 x 10(-6)M); (c) prevention of binding by cysteine, glutathione, penicillamine, and EDTA but not by imidazole or histidine; (d) binding of mercury in amounts up to 7 times the reduced glutathione concentration of the cells before combination with glutathione itself; (e) binding primarily to sulfhydryl groups of hemoglobin and to a small number of stromal sulfhydryl groups, but also to other non-sulfhydryl cellular ligands after saturation of the sulfhydryl groups. Associated with the binding is inhibition of glucose uptake, induction of loss of K(+), and decrease in osmotic fragility. These effects increase over the range of concentrations (1 x 10(-17) to 1 x 10(-15) moles of Hg/RBC) well below those that result in saturation of the cellular binding sites; above 1 x 10(-15) moles/RBC, the effects decrease as the cells become saturated.
D001692:Biological Transport; D003545:Cysteine; D004912:Erythrocytes / Q000378:metabolism*; D005978:Glutathione; D006454:Hemoglobins; D006801:Humans; D008628:Mercury / Q000378:metabolism*; D013438:Sulfhydryl Compounds
D006454:Hemoglobins; D013438:Sulfhydryl Compounds; D008628:Mercury; D005978:Glutathione; D003545:Cysteine
ERYTHROCYTES/metabolism; MERCURY/metabolism